Loading...
Loading...
Browse all stories on DeepNewz
VisitWhich demographic will primarily purchase the new OTC COVID-19 and flu test by Q1 2025?
Families with children • 25%
Elderly individuals • 25%
Young professionals • 25%
Healthcare workers • 25%
Market research reports and consumer surveys
FDA Authorizes First Over-the-Counter COVID-19 and Flu Test Outside Emergency Use
Oct 8, 2024, 04:22 PM
The FDA has granted marketing authorization for the first over-the-counter combination COVID-19 and flu test for use without a prescription. This at-home test, which uses a nasal swab sample, is designed for individuals experiencing respiratory symptoms and can deliver results for both COVID-19 and flu. The test is the first of its kind to be authorized outside of emergency use, joining other similar tests that were previously available only under emergency use authorization. The approval comes as flu season approaches, providing a valuable tool for families to manage respiratory illnesses at home.
View original story
18-24 • 25%
25-34 • 25%
35-44 • 25%
45+ • 25%
Less than 20% • 25%
20% to 40% • 25%
40% to 60% • 25%
More than 60% • 25%
New test leads market • 25%
Existing tests maintain dominance • 25%
Market share evenly distributed • 25%
Other outcome • 25%
Manufacturer A has largest share • 25%
Manufacturer B has largest share • 25%
Manufacturer C has largest share • 25%
Manufacturer D or others have largest share • 25%
Manufacturer A • 25%
Manufacturer B • 25%
Manufacturer C • 25%
Other • 25%
Walmart • 25%
CVS • 25%
Walgreens • 25%
Amazon • 25%
Yes • 50%
No • 50%
No • 50%
Yes • 50%
Accuracy issues • 25%
Price • 25%
Availability • 25%
Ease of use • 25%